Showing results (1-10 of 296) with videos related to
Sort By:
Pageof 30
Cell|April 4, 2020
Psychedelic Psychiatry's Brave New WorldDavid Nutt, David Erritzoe, Robin Carhart-HarrisScientific Reports|July 26, 2023
The difference between 'placebo group' and 'placebo control': a case study in psychedelic microdosingBalázs Szigeti, David Nutt, Robin Carhart-Harris, et al.Journal of Affective Disorders|February 29, 2024
Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivityDébora Copa, David Erritzoe, Bruna Giribaldi, et al.Psychological Medicine|January 22, 2024
Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depressionBalázs Szigeti, Brandon Weiss, Fernando E Rosas, et al.Translational Psychiatry|November 19, 2025
Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trialMarieke A G Martens, Bruna Giribaldi Cunha, David Erritzoe, et al.Molecular Psychiatry|April 25, 2025
Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprisesRebecca Harding, Neomi Singer, Matthew B Wall, et al.Frontiers in Psychology|September 4, 2018
DMT Models the Near-Death ExperienceChristopher Timmermann, Leor Roseman, Luke Williams, et al.Frontiers in Psychiatry|July 10, 2024
Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action"Julia Bornemann, James B Close, Kirran Ahmad, et al.Nature Medicine|April 12, 2022
Increased global integration in the brain after psilocybin therapy for depressionRichard E Daws, Christopher Timmermann, Bruna Giribaldi, et al.Acta Psychiatrica Scandinavica|October 30, 2020
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studiesKristoffer A A Andersen, Robin Carhart-Harris, David J Nutt, et al.Pageof 30